Local control in advanced head and neck cancer by combined modalities of treatment
β Scribed by Baby Jose; Yusuf Desmukh; Subhash C. Sharma
- Publisher
- John Wiley and Sons
- Year
- 1984
- Tongue
- English
- Weight
- 295 KB
- Volume
- 26
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
From July 1979 to January 1983, 20 patients with locally advanced head and neck cancer were treated with a combination of chemotherapy and irradiation with or without surgery. A majority of the patients were in the age range of 45 to 54 years. Eightyβfive percent of the patients were male. Seventyβfive percent of the patients had oral cavity lesions, the tongue being the most common site. Eighty percent of the patients had T~4~ lesion and 35% had N~3~ disease in the neck. A majority of the patients had combination chemotherapy, including bleomycin, methotrexate, and cisβplatinum (BMP). All patients received irradiation with megavoltage equipment and 55% of patients received a dose of 5,000 to 6,000 rads in 5β6 weeks time. The tumor was converted to be resectable in ten patients. Nine patients (45%) had the neck and primary tumor completely controlled, while six patients (30%) had partial control. Six of the ten patients who had resection had the tumor controlled at the primary site and neck. The median duration of followβup is 12 months (range, 4β32 months). The median survival of the whole group of patients is 12.5 months. A brief review of the current literature is also done in this paper.
π SIMILAR VOLUMES
## Abstract ## Purpose. The purpose of this study was to evaluate the role of neck lymph node (ND) in the combined dissection modality therapy for locoregionally advanced head and neck. ## Methods. We identified patients with N2βN3 head and neck cancers who were enrolled in three consecutive mul
## Background: The purpose of this study was to determine the feasibility and efficacy of hyperfractionated accelerated radiotherapy (hfrcb) combined with simultaneous chemotherapy with weekly cisplatin (cddp) in locally advanced inoperable head and neck cancer. ## Methods: From august 1999 to de